Forbes
@forbes·2.1M subscribers·11.3K videos
This Next Billion Dollar DNA Company Will Test Your Dog For A Healthier Life | Forbes
Posted
January 3, 2022
Views
5,782
Likes
234
Comments
40
Engagement
4.74%
January 3, 2022
5,782
234
40
4.74%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
5:59Now PlayingA dog lover who studied computer science and biology at Harvard, Ryan Boyko, 33, is the co-founder and CEO of Embark, a Boston-based company that tests dog DNA. He launched the company two years ago with his older brother Adam, a Cornell University genetics professor who specializes in canines. In addition to details about a dog’s breed, for $199, Embark tests for more than 160 genetic conditions that can predict whether an animal will develop ailments like bladder stones, heart disease or glaucoma. Since it made the product available in late May 2016, Embark has made more than 20,000 sales. In this interview, which has been edited and condensed, Boyko tells how he got Embark off the ground.
Adam Boyko is Ryan Boyko's older brother, not younger. Embark’s $72 million dollar revenue is an estimate made by Forbes in October 2021 for the 2021 financial year.
Read the full story on Forbes
Subscribe to FORBES
Stay Connected
Forbes newsletters
Forbes on Facebook
Forbes Video on Twitter
Forbes Video on Instagram
More From Forbes
Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
